Docetaxel
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22342 publications
Cost-effectiveness analysis of sintilimab versus docetaxel as second-line therapy for squamous non-small cell lung Cancer in China.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: October 30, 2026
Identification of ageing-related genes in prostate cancer with type 2 Diabetes using machine learning: a multi-omics study focusing on SOX4, PRNP, and FOXO4.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: October 29, 2026
Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: October 26, 2026
Exploring the interaction between extracellular matrix components of bone marrow and prostate cancer cells in a novel 3D model.
Journal: Research square
Published: October 24, 2026
Ocular Adverse Events Associated with Docetaxel and Paclitaxel: A Pharmacovigilance Disproportionality Analysis.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: October 22, 2026
EARLY DETECTION OF BONE METASTASIS BY WHOLE-BODY MRI AND TRIPLET THERAPY AFTER RADICAL PROSTATECTOMY: A CASE REPORT
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: October 22, 2026
Selection and Management of Patients With Resectable Gastric or Gastroesophageal Junction Cancer Receiving Perioperative FLOT: A Modified Delphi Consensus Approach.
Journal: JCO oncology practice
Published: October 20, 2026
Corrigendum to "Dual-targeting liposomal delivery of sorafenib and docetaxel for enhanced synergistic therapy in advanced hepatocellular carcinoma" [Pharmaceut. Sci. Adv. 2 (2024) 100046].
Journal: Pharmaceutical science advances
Published: October 20, 2026
An evaluation of sacituzumab tirumotecan for the treatment of NSCLC.
Journal: Expert opinion on biological therapy
Published: October 16, 2026
Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone-sensitive prostate cancer: the ARASENS and LATITUDE trials.
Journal: BJU international
Published: October 05, 2026
ROLE OF NEOADJUVANT THERAPY FOR PATIENTS WITH GASTRIC CANCER: MULTIDISCIPLINARY HOSPITAL WITH ONCOLOGY CENTER.
Journal: Georgian medical news
Published: October 04, 2026
Last Updated: 11/08/2026